Dr. Alexandra Dubinskaya, MD
99 N LA Cienega Blvd # 202m102, Beverly Hills, CA 90211 • +1-426-555-7341
Medical Education: Accredited U.S. Medical School (Class of 2012)
What This Doctor Actually Performs: CMS Medicare Utilization & Beverly Hills Percentiles
NPI #1356799340 • CBSA Regional • Obstetrics & Gynecology
Dr. Alexandra Dubinskaya, MD (NPI #1356799340) practices Obstetrics & Gynecology in Beverly Hills, CA (90211) with sub-specialty concentration in 46 Active CMS HCPCS Codes, recording 858 annual CMS services across 129 distinct beneficiaries—placing this practice as a focused low-volume boutique caseload (16.67th Beverly Hills percentile) (-0.38σ vs CA state mean, 24.48th statewide percentile).
Procedural volume for Dr. Dubinskaya is led by HCPCS 99214 (Gynecologic, Menopause HRT & Endocrine Follow-Up — 335 annual services, $130–$178 GPCI cash estimate), followed by CPT 76830 (Transvaginal Pelvic & Ovarian Diagnostic Ultrasound, 206/yr) and CPT 99213 (Established Women’s Health & Preventive Care Visit, 172/yr).
Self-pay new patient consultations with Dr. Dubinskaya (CPT 99204 GPCI-adjusted benchmark) estimate around $239.00 (community reported average: $239.00) with hybrid in-clinic and telehealth video consults, 19-minute average reception wait, and a 4.74/5 modern protocol openness score across 23 patient logs.
Clinical background for Dr. Dubinskaya (MD, NPI #1356799340) includes accredited doctoral training (2012, 14 yrs in practice) and virtual + in-office availability across CA.
Compared against Beverly Hills, CA Obstetrics & Gynecology peers
858 annual services across 129 beneficiaries
Standard deviations from CA Obstetrics & Gynecology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Gynecologic, Menopause HRT & Endocrine Follow-Up | 335 | 16.67th | $130 – $178 |
| 76830 | Transvaginal Pelvic & Ovarian Diagnostic Ultrasound | 206 | 20.67th | $167 – $229 |
| 99213 | Established Women’s Health & Preventive Care Visit | 172 | 13.67th | $102 – $139 |
| 58100 | Endometrial Sampling Biopsy w/ Cannula | 77 | 19.67th | $175 – $240 |
| 99204 | Comprehensive New Patient OB/GYN & Hormone Evaluation | 69 | 19.67th | $183 – $250 |
Are you Dr. Alexandra Dubinskaya? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Beverly Hills, CA:
<a href="https://dotmd.com/doctors/alexandra-dubinskaya-md-beverly-hills-ca-1356799340" title="Dr. Alexandra Dubinskaya, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1356799340.svg" alt="Dr. Alexandra Dubinskaya Obstetrics & Gynecology Badge" width="280" height="72" /></a>
Dr. Alexandra Dubinskaya, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Dubinskaya National Provider Identifier | NPI #1356799340 (MD) | CMS NPPES Registry (90211) |
| Dr. Dubinskaya Beverly Hills CMS Volume Rank | 16.67th Pct (858 CMS svcs; Z -0.378σ) | CMS Medicare Part B (CA Obstetrics & Gynecology) |
| Fair Cash-Pay New-Patient Benchmark | $239.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Beverly Hills, CA) |
| Waiting-Room Wait Time & Cash Friendliness | $239.00 avg paid • 19 min lobby wait | 23 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.96/5 Listening • 4.74/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Alexandra Dubinskaya
Other High-Volume Obstetrics & Gynecology Specialists in Beverly Hills, CA
Ranked strictly by CMS Medicare volumeDr. Dubinskaya Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Beverly Hills, CA.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Alexandra Dubinskaya community threads and patient logs by age, biological sex, dosage, and treatment duration.